Published Apr 19, 2023

Rethinking Psychedelics, Octopuses on MDMA, and The Master Key of Metaplasticity | Dr. Gül Dölen

Dr. Gül Dölen delves into the transformative realm of psychedelics, exploring their potential to redefine neurological therapies by unlocking critical brain periods and enhancing plasticity. She also critiques research methodologies and the political hurdles in scientific funding, advocating for curiosity-driven exploration.

Episode Highlights

Topics covered

Questions from this episode

- Can neuroscience explain consciousness?
  Asked by 97 people
- Should someone use psychedelics?
  Asked by 95 people
- I'd like to learn more about serotonin's role
  Asked by 84 people
- How can the venture ecosystem change?
  Asked by 63 people
- Episode of neuroplasticity
  Asked by 61 people
- Does psilocybin affect neuroplasticity?
  Asked by 56 people
- What are the latest findings on psilocybin?
  Asked by 46 people
- What are the positive and negative effects of psilocybin on the brain?
  Asked by 45 people
- What causes allergies?
  Asked by 20 people
- How does oxytocin affect the brain?
  Asked by 14 people
- What is the relationship between low neuroplasticity and psilocybin treatment?
  Asked by 11 people
- Explain more about neuroplasticity and brain reorganization after stroke
  Asked by 8 people
- Would LSD have the same brain benefits as psilocybin?
  Asked by 7 people
- Is there a revision of autism categorization?
  Asked by 6 people
- What drugs increase neuroplasticity?
  Asked by 5 people

Episode Highlights